Here are relevant reports on : clinical-trial-imaging-service-market
-
Dental Imaging Market by Product (Extraoral Imaging (CBCT, Panoramic), Intraoral Imaging (X-ray, Intraoral Camera, IOL Scanner)), Application (Endodontics, Implantology), & End User (Dental Hospitals, Dental Diagnostic Centers) - Global Forecast to 2030
The global dental imaging market, valued at US$3.08 billion in 2024, stood at US$3.26 billion in 2025 and is projected to advance at a resilient CAGR of 7.5% from 2025 to 2030, culminating in a forecasted valuation of US$4.69 billion by the end of the period. The prominent players in the dental imaging market include Envista Holdings Corporation (US), Planmeca Oy (Finland), ACTEON (UK), DENTSPLY SIRONA Inc. (US), Carestream Dental LLC (US), VATECH (South Korea), Owandy Radiology, Inc. (France), DÜRR DENTAL AG (Germany), Midmark Corporation (US), Genoray Co., Ltd. (South Korea), Asahi Roentgen Co., Ltd. (Japan), 3Shape (Denmark), PreXion, Inc. (US), Ningbo Runyes Medical Instrument Co. Ltd.(China), Cefla Medical Equipment (Italy), Apteryx Imaging (Canada), Yoshida Dental Mfg. Co., Ltd. (Japan), Align Technology Inc. (US), J. MORITA CORP (Japan), and FONA Srl (Italy).
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Preclinical Imaging Market by Product (Optical Imaging (Bioluminescence), Nuclear Imaging (PET, SPECT), MRI, Reagents (Luciferins, Infrared Dyes), Software), Application (Onco, Cardio), End User (Pharma, Biotech, Academic, CRO) - Global Forecast to 2030
The global preclinical imaging market, valued at US$3.36 billion in 2024, stood at US$3.53 billion in 2025 and is projected to advance at a resilient CAGR of 4.5% from 2025 to 2030, culminating in a forecasted valuation of US$4.39 billion by the end of the period.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Breast Imaging Market by Technology (Ionizing, Non-ionizing), Product (Breast Imaging Systems, Software and Services, Accessories), End User (Hospitals and Clinics, Diagnostic Imaging Centers, Breast Care Centers) - Global Forecast to 2028
The global breast imaging market, valued at US$4.1 billion in 2022, stood at US$4.4 billion in 2023 and is projected to advance at a resilient CAGR of 8.5% from 2023 to 2028, culminating in a forecasted valuation of US$6.6 billion by the end of the period.The increasing number of research grants, rising focus on contrast-based diagnostic solutions, and rising awareness in developing economies are expected to drive the market during the forecast period.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
3D Imaging Market by Hardware (3D Cameras, 3D Sensors, 3D Scanners), Software (Modeling, Scanning, Layout & Animation, Visualization & Rendering, Image Reconstruction), Technology (Stereoscopic Imaging, Laser-based Imaging) - Global Forecast to 2028
The global market for 3D Imaging market is projected to reach USD 88.4 billion by 2028, at a CAGR of 20.8% during the forecast period. Major vendors in the global 3D Imaging market are GE Healthcare (US), Autodesk (US), STMicroelectronics (Switzerland), Panasonic (Japan), Sony Corporation (Japan), Trimble (US), FARO Technologies (US), Philips (Netherlands), Google (US), Adobe (US), HP (US), Dassault Systemes (France), Bentley Systems (US), Lockheed Martin (US), Topcon (Japan), Able Software (US), Maxon (Germany), ESRI (US), Archilogic (Switzerland), Pix4D (Switzerland), Brainkey (US), Precismo (US), Kaarta (US), LightCode Photonics (Estonia), Vzense Technology (US), Capoom (Istanbul), Atomontage (US), Hivemapper (US), Shapr3D (Hungary), Innersight (UK).
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
North America Healthcare IT Market by Solution (Provider, Payer [Clinical {EHR, PHM, PACS & VNA, Telehealth, RCM, CDSS}, Nonclinical {Analytics, Pharmacy, Interoperability}]), Service (Claim, Billing), End User (Hospital, Payer) - Forecast to 2031
The North America healthcare IT market is projected to reach USD 529.06 billion by 2031, growing at a CAGR of 14.3% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 6150
- TOC Available:
-
Antimicrobial Resistance Surveillance Market by Solution (Kits, System, Surveillance Software, Service), Application (Clinical Diagnostics, Public Health Surveillance), End User (Hospitals, Clinics, Academic, Research Institutes) & Region - Global Forecast to 2028
The global antimicrobial resistance (AMR) surveillance market, valued at US$5.4 billion in 2021, stood at US$5.9 billion in 2023 and is projected to advance at a resilient CAGR of 5.6% from 2023 to 2028, culminating in a forecasted valuation of US$7.7 billion by the end of the period.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Europe Proteomics Market by Instrumentation [Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray], Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery) - Forecast to 2030
The Europe Proteomics market, valued at USD9.80 billion in 2024, stood at USD10.55 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of USD18.77 billion by the end of the period.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Proteomics Services Market by Service Type (Core Proteomics, Bioinformatics), Application (Clinical, Drug Discovery), End User (Biopharmaceuticals, Hospitals) - Global Forecast to 2030
The global proteomics services market, valued at US$8.06 billion in 2024, stood at US$8.77 billion in 2025 and is projected to advance at a resilient CAGR of 13.4% from 2025 to 2030, culminating in a forecasted valuation of US$16.46 billion by the end of the period. This growth is driven by advances in multiplexing, automation, and bioinformatics, which enable deeper analysis of protein interactions, biomarker discovery, and assay development, improving insights into therapeutic responses, diagnostics, and functional applications.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Flow Cytometry Market by Technology (Cell, Bead-based), Product [Cell Analyzer, Sorter, Antibodies, Assays & Kits (Apoptosis), Software], Service, Detection (Spectral), Application (Clinical, Research), End User, Competition - Global Forecast to 2034
The global flow cytometry market is projected to reach USD 10.57 billion by 2034, growing at a CAGR of 8.4% during the forecast period (2026–2034). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Stem Cell Assays Market Size by Type (Viability, Proliferation, Differentiation, Apoptosis), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instrument), Application (Regenerative Medicine, Clinical Research), End User - Global Forecast to 2027
The size of global stem cell assays market in terms of revenue was estimated to be worth USD 1.9 billion in 2022 and is poised to reach USD 4.5 billion by 2027, growing at a CAGR of 17.7% from 2022 to 2027. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: June 2022
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
